Osteoarthritis Therapeutics Market

Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecast to 2024

Report Code: PH 7393 Oct, 2019, by marketsandmarkets.com

[147 Pages Report] The osteoarthritis therapeutics market is expected to grow from USD 6.8 billion in 2019 to reach USD 10.1 billion by 2024, at a CAGR of 8.1%. This industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.

Osteoarthritis Therapeutics Market

Knee segment to witness the highest growth during the forecast period

Based on anatomy, the market is segmented into knee, hip, hand, and small-joint. The knee osteoarthritis segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period. This is attributed to a large number of patients suffering from knee osteoarthritis.

Viscosupplementation agents segment to dominate the osteoarthritis therapeutics market in 2018

Based on drug type, the market is segmented into viscosupplementation agents, nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids. The viscosupplementation agents segment accounted for the largest market share in 2018. The rising incidence and prevalence of knee osteoarthritis are supporting their adoption in the market.

Osteoarthritis Therapeutics Market

Europe was the largest regional market for osteoarthritis therapeutics in 2018

The osteoarthritis therapeutics market is segmented into Europe, North America, Asia Pacific, and Rest of the World. In 2018, Europe was the largest market for share, followed by North America. The rising incidence of osteoarthritis, rising geriatric population, and the increasing obesity rates in several European countries are the major factors driving the growth of the market in Europe.

Key Market Players

The prominent players operating in this market include Sanofi (France), Horizon Therapeutics (Ireland), Johnson & Johnson (US), GlaxoSmithKline Plc (UK), Bayer AG (Germany), Abbott (US), Pfizer (US), Eli Lilly (US), Anika Therapeutics (US), Novartis (Switzerland), Bioventus (US) Zimmer Biomet Holdings, Inc.(US), Flexion Therapeutics (US) and Fidia Farmaceutici s.p.a. (Italy).

Sanofi (France) is one of the leading players in the market in 2018. The company boasts of a broad product portfolio across the globe. Over the years, the company has maintained its leading position in the market.

Scope of the Report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

  • Anatomy, drug type, route of administration, distribution channel, purchasing pattern, and region

Geographies covered

North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and RoE), APAC (China, Japan, India, and RoAPAC), and the RoW (Latin America and the Middle East and Africa)

Companies covered

Major ten players covered, including
Sanofi (France), Horizon Therapeutics (Ireland), Johnson & Johnson (US), GlaxoSmithKline Plc (UK), Bayer AG (Germany), Abbott (US), Pfizer (US), Eli Lilly (US), Anika Therapeutics (US), and Flexion Therapeutics (US).

This research report categorizes the market into the following segments and subsegments:

Market, by Anatomy

  • Knee
  • Hip
  • Hand
  • Small Joints (Foot & Ankle and Wrist )

Market, by Drug Type

  • Viscosupplementation Agents
  • Nonsteroidal Anti-inflammatory Drugs
    • Naproxen
    • Aspirin
    • Diclofenac
    • Ibuprofen
    • Other NSAIDs
  • Analgesics
    • Duloxetine
    • Acetaminophen
  • Corticosteroids

    Market, by Route of Administration

    • Parenteral
    • Topical
    • Oral

    Market, by Distribution Channel

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

    Market, by Purchasing Pattern

    • Prescription Drug
    • Over-the-counter Drug

    Market, by Region

    • North America
      • US
      • Canada
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • RoE
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • Rest of the World

    Key Questions Addressed by the Report

    • What are the various osteoarthritis drugs and their respective market shares in the overall market?
    • Where will all these developments take the industry in the mid-to-long term?
    • What are the recent trends affecting the market?
    • Who are the key players in the market and how intense is the competition?
    • What are the pipeline drugs for osteoarthritis disease?

    To speak to our analyst for a discussion on the above findings, click Speak to Analyst

    Table of Contents

    1 Introduction (Page No. - 17)
        1.1 Objectives of the Study
        1.2 Market Definition
        1.3 Market Scope
               1.3.1 Markets Covered
               1.3.2 Years Considered for the Study
        1.4 Currency
        1.5 Limitations
        1.6 Stakeholders

    2 Research Methodology (Page No. - 20)
        2.1 Research Data
               2.1.1 Secondary Data
                        2.1.1.1 Key Data From Secondary Sources
               2.1.2 Primary Data
                        2.1.2.1 Key Data From Primary Sources
        2.2 Market Size Estimation
               2.2.1 Bottom-Up Approach
               2.2.2 Top-Down Approach
        2.3 Market Breakdown and Data Triangulation
        2.4 Assumptions for the Study

    3 Executive Summary (Page No. - 27)

    4 Premium Insights (Page No. - 31)
        4.1 Osteoarthritis Therapeutics Market Overview
        4.2 Europe: Market Share, By Anatomy (2018)
        4.3 Geographical Snapshot of the Market

    5 Market Overview (Page No. - 34)
        5.1 Introduction
        5.2 Market Dynamics
               5.2.1 Drivers
                        5.2.1.1 Rapid Growth in the Geriatric and Obese Populations and the Associated Increase in the Prevalence of Osteoarthritis
                        5.2.1.2 Increasing Incidence of Sports Injuries
               5.2.2 Restraints
                        5.2.2.1 Risk of Adverse Cardiovascular Events Associated With the Use of Nsaids in Osteoarthritis Treatment
               5.2.3 Opportunities
                        5.2.3.1 Emerging Markets
                        5.2.3.2 Strategic Collaborations Focused on New Product Development
               5.2.4 Challenges
                        5.2.4.1 Availability of Alternative Non-Drug Pain Management Therapies

    6 Osteoarthritis Therapeutics Market, By Anatomy (Page No. - 39)
        6.1 Introduction
        6.2 Knee Osteoarthritis
               6.2.1 Rising Obese and Geriatric Populations to Increase the Prevalence of Knee Osteoarthritis
        6.3 Hip Osteoarthritis
               6.3.1 Similar to Knee Osteoarthritis, Hip Osteoarthritis is More Common in the Geriatric and Obese Populations
        6.4 Hand Osteoarthritis
               6.4.1 Rising Prevalence of Shoulder Osteoarthritis to Drive Market Growth
        6.5 Small-Joint Osteoarthritis
               6.5.1 Rising Number of Ankle-Related Sports Injuries to Increase the Prevalence of Ankle Osteoarthritis

    7 Osteoarthritis Therapeutics Market, By Drug Type (Page No. - 45)
        7.1 Introduction
        7.2 Viscosupplementation Agents
               7.2.1 Viscosupplementation Agents Dominated the Market in 2018
        7.3 Nonsteroidal Anti-Inflammatory Drugs
               7.3.1 Nsaids Can Relieve Pain and Inflammation Without the Various Potential Adverse Effects Associated With Corticosteroids
                        7.3.1.1 Ibuprofen
                        7.3.1.2 Diclofenac
                        7.3.1.3 Aspirin
                        7.3.1.4 Naproxen
                        7.3.1.5 Other Molecules
        7.4 Analgesics
               7.4.1 Acetaminophen
               7.4.2 Duloxetine
        7.5 Corticosteroids

    8 Osteoarthritis Therapeutics Market, By Route of Administration (Page No. - 54)
        8.1 Introduction
        8.2 Oral Route
        8.3 Parenteral Route
        8.4 Topical Route

    9 Osteoarthritis Therapeutics Market, By Distribution Channel (Page No. - 58)
        9.1 Introduction
        9.2 Hospital Pharmacies
        9.3 Online Pharmacies
        9.4 Retail Pharmacies

    10 Osteoarthritis Therapeutics Market, By Purchasing Pattern (Page No. - 62)
         10.1 Introduction
         10.2 Prescription Drugs
                 10.2.1 Prescription Drugs to Account for A Larger Share of the Market
         10.3 Over-The-Counter Drugs
                 10.3.1 Ease of Purchase and Administration Resulting in A Rising Demand for Otc Drugs

    11 Osteoarthritis Therapeutics Market, By Region (Page No. - 65)
         11.1 Introduction
         11.2 Europe
                 11.2.1 Italy
                 11.2.2 Germany
                 11.2.3 Spain
                 11.2.4 France
                 11.2.5 UK
                 11.2.6 Rest of Europe
         11.3 North America
                 11.3.1 US
                 11.3.2 Canada
         11.4 Asia Pacific
                 11.4.1 Japan
                 11.4.2 China
                 11.4.3 India
                 11.4.4 Rest of Asia Pacific
         11.5 Rest of the World

    12 Competitive Landscape (Page No. - 115)
         12.1 Overview
         12.2 Market Ranking Analysis, 2018
         12.3 Competitive Scenario
                 12.3.1 Product Launches and Approvals, 2016–2019
                 12.3.2 Collaborations, 2016–2019
                 12.3.3 Expansions, 2016–2019
                 12.3.4 Acquisitions, 2016–2019
                 12.3.5 Other Developments
         12.4 Competitive Leadership Mapping
                 12.4.1 Vendor Inclusion Criteria
                 12.4.2 Visionary Leaders
                 12.4.3 Innovators
                 12.4.4 Dynamic Differentiators
                 12.4.5 Emerging Companies

    13 Company Profiles (Page No. - 120)
    (Business Overview, Products Offered, Recent Developments, MnM View)*
         13.1 Sanofi
         13.2 Horizon Therapeutics PLC
         13.3 Johnson & Johnson
         13.4 Glaxosmithkline PLC
         13.5 Bayer AG
         13.6 Abbott
         13.7 Pfizer, Inc.
         13.8 Eli Lilly
         13.9 Anika Therapeutics, Inc.
         13.10 Novartis
         13.11 Ferring Pharmaceuticals
         13.12 Bioventus
         13.13 Zimmer Biomet Holdings, Inc.
         13.14 Fidia Farmaceutici S.P.A.
         13.15 Flexion Therapeutics, Inc.

    *Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

    14 Appendix (Page No. - 141)
         14.1 Discussion Guide
         14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
         14.3 Available Customizations
         14.4 Related Reports
         14.5 Author Details


    List of Tables (146 Tables)

    Table 1 Osteoarthritis Therapeutics Market, By Anatomy, 2017–2024 (USD Million)
    Table 2 Knee Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
    Table 3 Hip Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
    Table 4 Hand Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
    Table 5 Small-Joint Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
    Table 6 Market, By Drug Type, 2017–2024 (USD Million)
    Table 7 Market for Viscosupplementation Agents, By Region, 2017–2024 (USD Million)
    Table 8 Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 9 Market for Nonsteroidal Anti-Inflammatory Drugs, By Region, 2017–2024 (USD Million)
    Table 10 Market for Ibuprofen, By Region, 2017–2024 (USD Million)
    Table 11 Market for Diclofenac, By Region, 2017–2024 (USD Million)
    Table 12 Market for Aspirin, By Region, 2017–2024 (USD Million)
    Table 13 Market for Naproxen, By Region, 2017–2024 (USD Million)
    Table 14 Market for Other Molecules, By Region, 2017–2024 (USD Million)
    Table 15 Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 16 Market for Analgesics, By Region, 2017–2024 (USD Million)
    Table 17 Market for Acetaminophen, By Region, 2017–2024 (USD Million)
    Table 18 Market for Duloxetine, By Region, 2017–2024 (USD Million)
    Table 19 Market for Corticosteroids, By Region, 2017–2024 (USD Million)
    Table 20 Market, By Route of Administration, 2017–2024 (USD Million)
    Table 21 Market for Oral Route of Administration, By Region, 2017–2024 (USD Million)
    Table 22 Market for Parenteral Route of Administration, By Region, 2017–2024 (USD Million)
    Table 23 Market for Topical Route of Administration, By Region, 2017–2024 (USD Million)
    Table 24 Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 25 Market for Hospital Pharmacies, By Region, 2017–2024 (USD Million)
    Table 26 Market for Online Pharmacies, By Region, 2017–2024 (USD Million)
    Table 27 Market for Retail Pharmacies, By Region, 2017–2024 (USD Million)
    Table 28 Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 29 Market for Prescription Drugs, By Region, 2017–2024 (USD Million)
    Table 30 Market for Over-The-Counter Drugs, By Region, 2017–2024 (USD Million)
    Table 31 Market, By Region, 2017–2024 (USD Million)
    Table 32 Europe: Market, By Country, 2017–2024 (USD Million)
    Table 33 Europe: Market, By Anatomy, 2017–2024 (USD Million)
    Table 34 Europe: Market, By Drug Type, 2017–2024 (USD Million)
    Table 35 Europe: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 36 Europe: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 37 Europe: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 38 Europe: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 39 Europe: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 40 Italy: Market, By Anatomy, 2017–2024 (USD Million)
    Table 41 Italy: Market, By Drug Type, 2017–2024 (USD Million)
    Table 42 Italy: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 43 Italy: Osteoarthritis Therapeutics Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 44 Italy: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 45 Italy: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 46 Italy: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 47 Germany: Market, By Anatomy, 2017–2024 (USD Million)
    Table 48 Germany: Market, By Drug Type, 2017–2024 (USD Million)
    Table 49 Germany: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 50 Germany: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 51 Germany: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 52 Germany: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 53 Germany: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 54 Spain: Market, By Anatomy, 2017–2024 (USD Million)
    Table 55 Spain: Market, By Drug Type, 2017–2024 (USD Million)
    Table 56 Spain: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 57 Spain: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 58 Spain: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 59 Spain: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 60 Spain: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 61 France: Market, By Anatomy, 2017–2024 (USD Million)
    Table 62 France: Market, By Drug Type, 2017–2024 (USD Million)
    Table 63 France: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 64 France: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 65 France: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 66 France: Osteoarthritis Therapeutics Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 67 France: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 68 UK: Market, By Anatomy, 2017–2024 (USD Million)
    Table 69 UK: Market, By Drug Type, 2017–2024 (USD Million)
    Table 70 UK: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 71 UK: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 72 UK: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 73 UK: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 74 UK: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 75 RoE: Market, By Anatomy, 2017–2024 (USD Million)
    Table 76 RoE: Market, By Drug Type, 2017–2024 (USD Million)
    Table 77 RoE: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 78 RoE: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 79 RoE: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 80 RoE: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 81 RoE: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 82 North America: Market, By Country, 2017–2024 (USD Million)
    Table 83 North America: Osteoarthritis Therapeutics Market, By Anatomy, 2017–2024 (USD Million)
    Table 84 North America: Market, By Drug Type, 2017–2024 (USD Million)
    Table 85 North America: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 86 North America: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 87 North America: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 88 North America: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 89 North America: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 90 US: Market, By Anatomy, 2017–2024 (USD Million)
    Table 91 US: Market, By Drug Type, 2017–2024 (USD Million)
    Table 92 US: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 93 US: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 94 US: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 95 US: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 96 US: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 97 Canada: Market, By Anatomy, 2017–2024 (USD Million)
    Table 98 Canada: Market, By Drug Type, 2017–2024 (USD Million)
    Table 99 Canada: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 100 Canada: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 101 Canada: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 102 Canada: Osteoarthritis Therapeutics Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 103 Canada: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 104 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
    Table 105 Asia Pacific: Market, By Anatomy, 2017–2024 (USD Million)
    Table 106 Asia Pacific: Market, By Drug Type, 2017–2024 (USD Million)
    Table 107 Asia Pacific: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 108 Asia Pacific: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 109 Asia Pacific: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 110 Asia Pacific: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 111 Asia Pacific: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 112 Japan: Market, By Anatomy, 2017–2024 (USD Million)
    Table 113 Japan: Market, By Drug Type, 2017–2024 (USD Million)
    Table 114 Japan: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 115 Japan: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 116 Japan: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 117 Japan: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 118 Japan: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 119 China: Osteoarthritis Therapeutics Market, By Anatomy, 2017–2024 (USD Million)
    Table 120 China: Market, By Drug Type, 2017–2024 (USD Million)
    Table 121 China: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 122 China: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 123 China: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 124 China: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 125 China: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 126 India: Market, By Anatomy, 2017–2024 (USD Million)
    Table 127 India: Market, By Drug Type, 2017–2024 (USD Million)
    Table 128 India: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 129 India: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 130 India: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 131 India: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 132 India: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 133 RoAPAC: Market, By Anatomy, 2017–2024 (USD Million)
    Table 134 RoAPAC: Market, By Drug Type, 2017–2024 (USD Million)
    Table 135 RoAPAC: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 136 RoAPAC: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 137 RoAPAC: Osteoarthritis Therapeutics Market, By Route of Administration, 2017–2024 (USD Million)
    Table 138 RoAPAC: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 139 RoAPAC: Market, By Purchasing Pattern, 2017–2024 (USD Million)
    Table 140 RoW: Market, By Anatomy, 2017–2024 (USD Million)
    Table 141 RoW: Market, By Drug Type, 2017–2024 (USD Million)
    Table 142 RoW: Market for Analgesics, By Type, 2017–2024 (USD Million)
    Table 143 RoW: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
    Table 144 RoW: Market, By Route of Administration, 2017–2024 (USD Million)
    Table 145 RoW: Market, By Distribution Channel, 2017–2024 (USD Million)
    Table 146 RoW: Market, By Purchasing Pattern, 2017–2024 (USD Million)


    List of Figures (34 Figures)

    Figure 1 Osteoarthritis Therapeutics Market Segmentation
    Figure 2 Research Design
    Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
    Figure 4 Market: Bottom-Up Approach
    Figure 5 Market: Top-Down Approach
    Figure 6 Data Triangulation Methodology
    Figure 7 Market, By Anatomy, 2019 vs 2024 (USD Billion)
    Figure 8 Market, By Drug Type, 2019 vs 2024 (USD Billion)
    Figure 9 Market, By Route of Administration, 2019 vs 2024 (USD Billion)
    Figure 10 Osteoarthritis Therapeutics Market, By Distribution Channel, 2019 vs 2024 (USD Billion)
    Figure 11 Market, By Purchasing Pattern, 2019 vs 2024 (USD Billion)
    Figure 12 Market, By Region, 2019 vs 2024 (USD Billion)
    Figure 13 High and Growing Prevalence of Osteoarthritis is the Major Factor Driving the Growth of This Market
    Figure 14 Knee Osteoarthritis Therapeutics Segment to Dominate the European Market in 2019
    Figure 15 China to Register the Highest CAGR During the Forecast Period
    Figure 16 Market: Drivers, Restraints, Opportunities, and Challenges
    Figure 17 Geriatric Population, By Region, 2017 vs 2050
    Figure 18 Europe: Osteoarthritis Therapeutics Market Snapshot
    Figure 19 Asia Pacific: Market Snapshot
    Figure 20 Key Developments in the Market From January 2016 to August 2019
    Figure 21 Top 5 Companies in the Market
    Figure 22 Global Market: Competitive Leadership Mapping, 2019
    Figure 23 Sanofi: Company Snapshot (2018)
    Figure 24 Horizon Therapeutics PLC: Company Snapshot (2018)
    Figure 25 Johnson & Johnson: Company Snapshot (2018)
    Figure 26 Glaxosmithkline PLC: Company Snapshot
    Figure 27 Bayer AG: Company Snapshot (2018)
    Figure 28 Abbott: Company Snapshot (2018)
    Figure 29 Pfizer, Inc.: Company Snapshot (2018)
    Figure 30 Eli Lilly: Company Snapshot (2018)
    Figure 31 Anika Therapeutics, Inc.: Company Snapshot (2018)
    Figure 32 Novartis: Company Snapshot (2018)
    Figure 33 Zimmer Biomet Holdings, Inc.: Company Snapshot (2018)
    Figure 34 Flexion Therapeutics: Company Snapshot (2018)

    The study involved four major activities in estimating the current market size of the osteoarthritis therapeutic market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    Secondary Research

    In the secondary research process, sources such as Centers for Disease Control and Prevention, Canadian Orthopaedic Foundation, National Health Service, National Center for Biotechnology Information, US Food and Drug Administration, Osteoarthritis Research Society International, Osteoarthritis World Association, World Health Organization, corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements), research journals, press releases, and trade, business, and professional associations were referred to identify and collect information for this study.

    Primary Research

    The osteoarthritis therapeutics market comprises several stakeholders, such as osteoarthritis drug manufacturers, vendors, and distributors. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Following is a breakdown of primary respondents:

    Osteoarthritis Therapeutics Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the osteoarthritis therapeutics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry and markets have been identified through extensive secondary research.
    • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the osteoarthritis therapeutics industry.

    Report Objectives

    • To define, describe, and forecast the global market based on anatomy, drug type, route of administration, distribution channel, purchasing pattern, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World
    • To profile key market players and comprehensively analyze their product portfolios, market positions, and core competencies3
    •  To track and analyze competitive developments such as product launches, partnerships, and acquisitions in the market

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
    • Company Information: Detailed analysis and profiling of additional market players (Up to 5)
    Report Code
    PH 7393
    Published ON
    Oct, 2019
    Choose License Type
    BUY NOW
    • SHARE
    X
    Request Customization
    Speak to Analyst
    Speak to Analyst
    OR FACE-TO-FACE MEETING
    PERSONALIZE THIS RESEARCH
    • Triangulate with your Own Data
    • Get Data as per your Format and Definition
    • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
    • Any level of Personalization
    REQUEST A FREE CUSTOMIZATION
    LET US HELP YOU!
    • What are the Known and Unknown Adjacencies Impacting the Osteoarthritis Therapeutics Market
    • What will your New Revenue Sources be?
    • Who will be your Top Customer; what will make them switch?
    • Defend your Market Share or Win Competitors
    • Get a Scorecard for Target Partners
    REQUEST A FREE WORKSHOP
    ADJACENT MARKETS
    REQUEST BUNDLE REPORTS
    ONLINE CHAT
    +1-888-600-6441
    • Call Us
    • +1-888-600-6441 (Corporate office hours)
    • +1-888-600-6441 (US/Can toll free)
    • +44-800-368-9399 (UK office hours)
    CONNECT WITH US
    ABOUT TRUST ONLINE
    © MarketsandMarkets Research Private Ltd. All rights reserved
    ...

    Digital Virtual Assistant - MarketsandMarkets

    ...

    Digital Virtual Assistant - MarketsandMarkets

    Home